The ultra-modern Pharmaceutical Micro Robots Market has greatly revolutionized the pharmaceutical and healthcare industry with miniature robotic systems for microscale medicine. This is an innovative approach to drug delivery, diagnostic and surgical procedures that can be achieved through the use of tiny robots called micro robots measuring between a few millimetres to sub-millimeter in diameter. These devices have the capability of traversing the human body to specific destinations better than any other equipment.
Another way pharmaceutical micro robots are employed is through targeted drug delivery. These small-sized robots may be engineered to transport drugs directly into certain cells or tissues hence minimizing systemic toxicities as well as improving therapeutic efficiency. The fact that these micro-robots can go through complex biological settings, including blood vessels and organs, makes it possible to reach areas where diseases come from more accurately.
Pharmaceutical Micro Robots Market is also transforming surgical procedures. Micro robots allow for minimally invasive surgeries thereby reducing traditional invasive surgical approaches which take longer time to heal. Small sized gadgets like these are able to move along intricate anatomical structures performing actions like suturing or removing damaged cells. Indeed, there are prospects that this could reduce damages on patients’ bodies, hasten healing as well as improve outcomes.
In addition, Pharmaceutical Micro Robots Market enhances diagnostic capabilities. For instance, microscopic bots can be fitted with imaging and sensing devices making it possible for doctors perform real-time monitoring and see internal parts of our bodies in picture form. This aids in early detection of diseases as well as facilitate treatment planning and intervention by having enough data about them. In effect, their ability to access remote areas within the body creates new possibilities for diagnostics using such minuscule robots.
One major obstacle in the Pharmaceutical Micro Robots market involves how these miniature products are designed and controlled since they are always complicated. It requires highly developed engineering skills together with control systems that ensure both movement accuracy and functional effectiveness at such scales (microscale). Moreover, biocompatibility and the possibilities of immune response towards these microbots must also be carefully examined. Engineers, biomedical scientists, and healthcare practitioners are continuously working on overcoming these challenges through research partnerships that enhance the market.
Moreover, there is a growing focus in developing swarm robotics as the Pharmaceutical Micro Robots Market continues to advance – groups of micro-robots working together to perform complex tasks. This emulates natural processes in which various microbial species work together for efficient and adaptive functions. By employing swarm robotics in medicine, it would be possible to increase the potential of individual micro robots to act collectively for purposes like tissue healing or drug delivery as well as diagnostics.
Another driving force towards evolving this market involves the exploration into biohybrid micro robots-combining biological with man-made elements. These hybrid systems merge biological cells with robotic structures in order to tap on specific functionalities of living cells such as self-propulsion or target cell attraction by incorporating them in artificial labs. The complexity of human body biology can be bridged by using Biohybrid-microbotics which combine precision surgical skills among others typical of robotics.
The Micro Robots Market size was valued at USD 30.20 billion in 2022 and is projected to grow from USD 35.27 billion in 2023 to USD 104.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.79% during the forecast period (2023 - 2030). The increasing applications of micro-robots in various end-user industries and increasing demand for minimally invasive surgical procedures are driving the market growth.
Minimally invasive surgical procedures are becoming more and more common because they require fewer procedures, have shorter hospital stays, are more exact, leave fewer scars, and are less painful. Medical displays allow improved diagnostic picture visibility by exhibiting even the tiniest alteration in tissues and cells, leading to more accurate and successful procedures. As technology in the area continues to advance, doctors are able to perform robotic surgeries more swiftly without compromising patient safety.
Furthermore, microsurgery robots are frequently used in oncological, cardiovascular, and neurological treatments. Increasingly surgical procedures are expected to be performed with robotic aid as more advanced surgical robots are deployed in hospitals and outpatient surgery facilities. In response to the rising demand, manufacturers of microsurgery robots are creating novel, cutting-edge technologies, and products. For instance, in October 2021, Medtronic (Ireland) received the European conformity Mark for their Hugo robotic-assisted surgery (RAS) system for gynecologic and urological procedures. With this approval, now Medtronic has access to the European market for this device and giving it an edge over its competitors. Therefore, an increasing demand for minimally invasive treatments and initiatives taken by governments such as funding to enhance the efficiency of microsurgery robots is expected to foster the market’s growth.
Furthermore, surgical robots are becoming more sophisticated as a result of technical improvement, offering a broader range of movement and precise dissection. Similar to this, modern visualization tools like binocular lenses, high-resolution HD cameras, and amplified 3D vision give surgeons more comfort and better dexterity. Robotic towers and arms can enhance control and coordination and lessen errors brought on by weariness.
Figure 1: Key Advantages of Robotic SurgerySource: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The market segments of Micro Robots, based on mode of operation, includes autonomous, semi-autonomous, and tele operated. The semi-autonomous segment is to hold the majority share in 2022 in the Micro Robots Market revenue. This is due to their high levels of adaptability to various circumstances and environments; they are versatile and widely used. In addition, Autonomous robots are expected to grow the fastest due to their ability to sense their surroundings. For instance, they use laser scanners, microphones, cameras, radars, and other image recognition software, the level of technology used is dependent on the complexity of the autonomous robot.
August 2020: Medtronic (Ireland) launched InterStim Micro Neurostimulator in U.S. InterStim micro robot therapy is an FDA-approved treatment for overactive bladder and urinary retention. With InterStim Therapy, an implantable device sends mild electrical pulses to the sacral nerves to reduce symptoms of bladder control problems, so you can get back to living.
The Micro Robots Market segmentation is based on a material type, that includes bio-hybrid and synthetic. The bio-hybrid segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. This is due to the rising use of bio-hybrid materials in various end use industries including automotive, manufacturing and healthcare among others. In addition, Bio-hybrid materials may benefit from onboard actuation, sensing, control, and execution of a variety of medical procedures, such as targeted drug administration, single-cell manipulation, and cell microsurgery.
Figure 2: MICRO ROBOTS MARKET, BY MATERIAL TYPE, 2022 & 2030 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Market segmentation of Micro Robots is based on end-user that includes hospitals and clinics, ambulatory surgical centers (ASCs), and others. The hospitals and clinics segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. This is due to the rising number of inpatient visits and the increasing number of minimally invasive surgical procedures in hospitals. Moreover, hospitals are equipped with advanced surgical robots to improve the quality of care and patient outcomes. According to an NCBI study, of 73 hospitals in the US, 23 of them had performed robotic-assisted surgery, which is expected to rise further. Therefore, the rising number of inpatient visits and the increasing number of surgical procedures drove the market growth in this segment.
May 2022: Clearpath Robotics (Canada) launched TurtleBot 4. - the next generation of the world’s most popular open-source robotics platform. TurtleBot 4 is a low-cost, fully expandable mobile robotics platform with improved sensing, increased payload capacity, ROS 2 support, and auto-docking capabilities for educators, researchers, and developers.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America micro robots market accounted for the largest market share in 2022. This is attributed to the growing financial capacity to invest in robotic systems, anticipated collaborations with among companies, rising acceptance of surgical robot use in clinical settings, and growing public awareness of computer-assisted procedures. In addition, numerous manufacturers in North America are striving to develop innovative and creative microrobots, which is anticipated to increase sales of microrobots. Additionally, it is anticipated that the incidence of cardiovascular disease would raise demand for minimally invasive operations, increasing the need for robotic surgical equipment in the region.
Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MICRO ROBOTS MARKET BY REGION 2022 & 2030 (USD Bn)Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe micro robots market is expected to account for the second-largest market share due to the presence of well-established industrial clusters and R&D centers that focus on developing advanced products for various applications such as healthcare, military & defense, automotive, etc., across different verticals. Further, the Germany market of micro robots was attributed to holding the largest market share, and the UK market of micro robots is expected to fastest-growing market in the European region.
The Asia-Pacific micro robots market is expected to grow at the fastest rate from 2023 to 2030. This is due to the increased chronic disease prevalence, an aging population, the creation of new products, and an increase in the number of international players operating in the region. Moreover, China market of micro robots is expected to hold the largest market share, and India market of micro robots is expected fastest-growing market in the Asia-Pacific region.
Furthermore, India is rapidly expanding in terms of healthcare research and development, whereas Japan has a robust research infrastructure and is home to significant pharmaceutical companies. In addition, China presently outpaces the US in terms of robot density and is expected to have significant growth potential in the microrobot industry due to its large expenditures in industrial automation, in the market for the micro robots.
The Rest of the World includes the Middle East, Africa, and Latin America. The main factors influencing the growth of micro robots in the Middle East and Africa are the increase in the geriatric population, recent advancements in robot manufacturing system technology, and the increase in the use of these robotic applications. In addition, governments in this region are also investing heavily in R&D activities to develop new and innovative applications for micro-robots in the region.
The Micro Robots Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Thermo Fisher Scientific (US), Seiko Epson Corporation (Japan), QinetiQ (UK), and Medtronic (Ireland) dominate the market of micro robots due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
One of the key players Thermo Fisher Scientific (US) is engaged in analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others. The company helps its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to the market, and increase the productivity of the laboratory. It has five premier brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services, through which it offers an unmatched combination of innovative technologies, purchasing convenience, and comprehensive services.
The company has a global presence across more than 50 countries. For instance, in In March 2018, Thermo Fisher Scientific (US) launched inSPIRE vertical modular robotic platform designed to integrate multiple instruments in an easy-to-use, space-saving solution. It aims to provide intuitive control of all integrated systems, both online and offlins, and uses the Thermo Scientific Spinnaker XT robot. As a microplate mover with built-in vision capability, Spinnaker XT can identify potential positional issues and take corrective actions to improve sample safety without interrupting the system’s operation.
Key Companies in the Market of Micro Robots Include
Micro Robots Industry Developments
November 2022: Rockwell Automation (US) collaborated with Comau (Italy). It helps organizations of all sizes to accelerate the adoption of robotic applications by overcoming the skills gap related to robot programming.
May 2018: ReconRobotics (US) has launched Throwbot 2 robot.The Throwbot 2 (TB2) robot is a throwable micro-robot platform that enables operators to obtain instantaneous video and audio reconnaissance within indoor or outdoor environments.
September 2018: Medtronic (Ireland) acquired Mazor Robotics (Israel), to become a leader in spinal surgery using guided robotics, which is the largest amount ever paid for an Israeli company in the medical sector.
March 2021: Memic Innovative Surgery (Israel) received regulatory approval from the US FDA for their robotically assisted surgical device, Hominis. It is the first FDA-approved device for transvaginal hysterectomy. It is designed to replicate the motions and capabilities of a surgeon's arms, with shoulder, elbow, and wrist joints, allowing the surgical robot device to access and reach through areas not possible with other robots.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)